Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 70 articles:
HTML format
Text format



Single Articles


    October 2018
  1. WIELAND A, Kohli R
    Non-Alcoholic Steatohepatitis as a Growing Indication for Liver Transplantation: The Evolving Gender and Ethnic Trends.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0373.
    PubMed     Text format     Abstract available


  2. ASKGAARD G, Kjaer MS, Tolstrup JS
    Opportunities to Prevent Alcoholic Liver Cirrhosis in High-risk Populations: A Systematic Review With Meta-analysis.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0282.
    PubMed     Text format     Abstract available


  3. ESTEVEZ J, Yang JD, Leong J, Nguyen P, et al
    Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0261.
    PubMed     Text format     Abstract available


  4. SHAH T, Tapper EB
    ERCP in Patients With Cirrhosis: "Risky Business" Or "Just Do It"?
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0271.
    PubMed     Text format     Abstract available


  5. YIP TC, Chan HL, Tse YK, Lam KL, et al
    On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0247.
    PubMed     Text format     Abstract available


  6. AGARWAL PD, Lucey MR
    Genetic Variations Linked to Hepatocellular Carcinoma: Personalized Medicine Takes a Step Forward.
    Am J Gastroenterol. 2018 Oct 5. pii: 10.1038/s41395-018-0260.
    PubMed     Text format     Abstract available


    September 2018
  7. NEY M, Tangri N, Dobbs B, Bajaj J, et al
    Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis.
    Am J Gastroenterol. 2018 Sep 28. pii: 10.1038/s41395-018-0243.
    PubMed     Text format     Abstract available


  8. LEAL C, Prado V, Colan J, Chavez-Rivera K, et al
    Adverse Events and Acute Chronic Liver Failure in Patients With Cirrhosis Undergoing Endoscopic Retrograde Cholangiopancreatography: A Multicenter Matched-Cohort Study.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0218.
    PubMed     Text format     Abstract available


  9. PETRICK JL, Thistle JE, Zeleniuch-Jacquotte A, Zhang X, et al
    Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0207.
    PubMed     Text format     Abstract available


    July 2018
  10. ACHARYA C, Bajaj JS
    Current Management of Hepatic Encephalopathy.
    Am J Gastroenterol. 2018 Jul 13. pii: 10.1038/s41395-018-0179.
    PubMed     Text format     Abstract available


  11. ADEBAYO D, Neong SF, Wong F
    Refractory Ascites in Liver Cirrhosis.
    Am J Gastroenterol. 2018 Jul 5. pii: 10.1038/s41395-018-0185.
    PubMed     Text format     Abstract available


    June 2018
  12. VIOLI F, Talerico G, Basili S
    A Closer Look at Platelet Count and Prediction of Bleeding in Cirrhotic Patients.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0191.
    PubMed     Text format    


  13. HUSSEN N, Zhu L, Tetangco E, Ellison S, et al
    Hepatoptosis in a Patient with Alcoholic Hepatitis.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0182.
    PubMed     Text format    


  14. GIANNINI EG, Bodini G, Furnari M, Marabotto E, et al
    A Closer Look at Factors Associated With Bleeding in Cirrhotic Patients.
    Am J Gastroenterol. 2018 Jun 18. pii: 10.1038/s41395-018-0128.
    PubMed     Text format    


  15. GIANNINI EG, Moscatelli A, Pellegatta G, Vitale A, et al
    Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.
    Am J Gastroenterol. 2018 Jun 18. pii: 10.1038/s41395-018-0131.
    PubMed     Text format     Abstract available


  16. LEE EW, Saab S, Kaldas F, Fletcher S, et al
    Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy.
    Am J Gastroenterol. 2018 Jun 14. pii: 10.1038/s41395-018-0109.
    PubMed     Text format     Abstract available


  17. HUANG R, Wang J, Xia J, Zhang Z, et al
    Platelet Count and Prediction of Bleeding in Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2018 Jun 12. pii: 10.1038/s41395-018-0152.
    PubMed     Text format    


  18. STICKEL F, Buch S, Nischalke HD, Weiss KH, et al
    Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related Cirrhosis.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0118.
    PubMed     Text format     Abstract available


  19. BAJAJ JS, Tandon P, O'Leary JG, Biggins SW, et al
    The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0119.
    PubMed     Text format     Abstract available


  20. SHIN JW, Jung SW, Lee SB, Lee BU, et al
    Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0093.
    PubMed     Text format     Abstract available


  21. MOURAD FH, Leong RW
    Gas In The Hepatic Portal Venous System Associated With Ischemic Colitis.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0110.
    PubMed     Text format    


  22. MITSIALIS V, Lee LS
    Metastasis of Hepatocellular Carcinoma to Distal Colon Associated With Inferior Mesenteric Arteriovenous Fistula and Tumor Thrombus: a Case Report.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0101.
    PubMed     Text format    


  23. BAJAJ JS, Acharya C, Fagan A, White MB, et al
    Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
    Am J Gastroenterol. 2018 Jun 6. pii: 10.1038/s41395-018-0085.
    PubMed     Text format     Abstract available


  24. LAI JC, Tandon P
    How I Approach It: Improving Nutritional Status in Patients With Cirrhosis.
    Am J Gastroenterol. 2018 Jun 5. pii: 10.1038/s41395-018-0080.
    PubMed     Text format    


    May 2018
  25. HERNAEZ R, El-Serag HB
    How we approach it: treatment options for hepatocellular carcinoma.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0008.
    PubMed     Text format    


    April 2018
  26. GINER R
    Spanish Women Hepatologists: Breaking The Glass Ceiling?
    Am J Gastroenterol. 2018;113:622-623.
    PubMed     Text format    


  27. BRUMBLE L, Keaveny AP
    Editorial: The Risky Business of Fungal Infections in Patients with Cirrhosis.
    Am J Gastroenterol. 2018;113:564-566.
    PubMed     Text format     Abstract available


    March 2018
  28. NEIJENHUIS M, Gevers TJG, Atwell TD, Gunneson TJ, et al
    Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.
    Am J Gastroenterol. 2018 Mar 20. pii: ajg201818. doi: 10.1038/ajg.2018.
    PubMed     Text format     Abstract available


  29. STICKEL F, Buch S, Nischalke HD, Weiss KH, et al
    Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
    Am J Gastroenterol. 2018 Mar 13. pii: 10.1038/s41395-018-0041.
    PubMed     Text format     Abstract available


  30. TAPPER EB, Parikh ND, Waljee AK, Volk M, et al
    Diagnosis of Minimal Hepatic Encephalopathy: A Systematic Review of Point-of-Care Diagnostic Tests.
    Am J Gastroenterol. 2018 Mar 13. pii: ajg20186. doi: 10.1038/ajg.2018.
    PubMed     Text format     Abstract available


  31. THOMSON MJ, Tapper EB, Lok ASF
    Dos and Don'ts in the Management of Cirrhosis: A View from the 21st Century.
    Am J Gastroenterol. 2018 Mar 9. pii: 10.1038/s41395-018-0028.
    PubMed     Text format    


    December 2017
  32. HUANG YW, Lee CL, Yang SS, Fu SC, et al
    Corrigendum: Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Am J Gastroenterol. 2017 Dec 26. pii: ajg2017494. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  33. BASILI S, Raparelli V, Napoleone L, Talerico G, et al
    Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.
    Am J Gastroenterol. 2017 Dec 19. pii: ajg2017457. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  34. LAI JC, Covinsky KE, McCulloch CE, Feng S, et al
    The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis.
    Am J Gastroenterol. 2017 Dec 12. pii: ajg2017443. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  35. HARMS MH, Lammers WJ, Thorburn D, Corpechot C, et al
    Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.
    Am J Gastroenterol. 2017 Dec 12. pii: ajg2017440. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  36. BUNCHORNTAVAKUL C, Reddy KR
    HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017435. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  37. VARKARIS A, Lewis DW, Nugent FW
    Preserved Liver Transplant After PD-1 Pathway Inhibitor for Hepatocellular Carcinoma.
    Am J Gastroenterol. 2017;112:1895-1896.
    PubMed     Text format    


  38. LIU K, Wong VW, Lau K, Liu SD, et al
    Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.
    Am J Gastroenterol. 2017;112:1812-1823.
    PubMed     Text format     Abstract available


  39. BARATTA F, Pastori D, Polimeni L, Bucci T, et al
    Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.
    Am J Gastroenterol. 2017;112:1832-1839.
    PubMed     Text format     Abstract available


    October 2017
  40. SINGAL AG
    CON: Hepatocellular Carcinoma Surveillance: In Need of Higher-Quality Data.
    Am J Gastroenterol. 2017 Oct 10. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  41. PARIKH ND
    PRO: Hepatocellular Carcinoma Surveillance: A Useful Tool Against the Rising Tide of HCC.
    Am J Gastroenterol. 2017 Oct 3. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  42. KECK C, Shetty A, Mischen B, Willner I, et al
    Hepatic Splenosis Masquerading as Hepatocellular Carcinoma in a Chronic Hepatitis C Patient.
    Am J Gastroenterol. 2017;112:1493.
    PubMed     Text format    


  43. PRICE JC, Tien PC
    Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?
    Am J Gastroenterol. 2017;112:1506-1507.
    PubMed     Text format     Abstract available


    September 2017
  44. UNGPRASERT P, Crowson CS, Simonetto DA, Matteson EL, et al
    Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976-2013.
    Am J Gastroenterol. 2017 Sep 5. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  45. ARGO CK, Caldwell SH
    Editorial: Severe Acute Liver Injury: Cause Connects to Outcome.
    Am J Gastroenterol. 2017;112:1397-1399.
    PubMed     Text format     Abstract available


  46. CHALASANI N, Reddy KRK, Fontana RJ, Barnhart H, et al
    Idiosyncratic Drug Induced Liver Injury in African-Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians.
    Am J Gastroenterol. 2017;112:1382-1388.
    PubMed     Text format     Abstract available


  47. KOCH DG, Speiser JL, Durkalski V, Fontana RJ, et al
    The Natural History of Severe Acute Liver Injury.
    Am J Gastroenterol. 2017;112:1389-1396.
    PubMed     Text format     Abstract available


    August 2017
  48. PIANO S, Morando F, Carretta G, Tonon M, et al
    Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections.
    Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  49. TSENG TC, Liu CJ, Su TH, Yang WT, et al
    Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  50. SCHAFFELLNER S, Stadlbauer V, Sereinigg M, Miller H, et al
    Niacin-Associated Acute Hepatotoxicity Leading to Emergency Liver Transplantation.
    Am J Gastroenterol. 2017;112:1345-1346.
    PubMed     Text format    


  51. LUEDKE C, Ravindra K, Hertzberg B, Berg C, et al
    A Rapidly Enlarging Mullerian-Derived Hepatic Adenomyoma Clinically Mimicking Hepatic Adenoma in a Pregnant Woman.
    Am J Gastroenterol. 2017;112:1217.
    PubMed     Text format    


  52. GEORGE NE, Raghavapuram S, Banerjee D, Al-Shoha M, et al
    Ectopic Hepatocellular Carcinoma within a Choledochal Cyst Diagnosed Using Single-Operator Digital Cholangioscopy.
    Am J Gastroenterol. 2017;112:1347-1348.
    PubMed     Text format    


  53. BUGIANESI E, Bizzarri C, Rosso C, Mosca A, et al
    Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2017;112:1277-1286.
    PubMed     Text format     Abstract available


    June 2017
  54. KANWAL F, Tansel A, Kramer JR, Feng H, et al
    Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013.
    Am J Gastroenterol. 2017 Jun 13. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  55. KAMAL S, Khan MA, Seth A, Cholankeril G, et al
    Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2017 Jun 6. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  56. LIU J, Ghaziani TT, Wolf JL
    Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management.
    Am J Gastroenterol. 2017;112:838-846.
    PubMed     Text format     Abstract available


    May 2017
  57. KHAN SA, Pham C, Seah D, Ranatunga D, et al
    Acute Life-Threatening Portal Hypertension After Portosystemic Shunt Embolization.
    Am J Gastroenterol. 2017;112:816-818.
    PubMed     Text format    


  58. LO GH
    Did Carvedilol Really Have More Severe Adverse Events than Propranolol in Cirrhotic Patients?
    Am J Gastroenterol. 2017;112:808.
    PubMed     Text format    


  59. SARKAR M, Wellons M, Cedars MI, VanWagner L, et al
    Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Am J Gastroenterol. 2017;112:755-762.
    PubMed     Text format     Abstract available


  60. MCPHERSON S, Hardy T, Dufour JF, Petta S, et al
    Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.
    Am J Gastroenterol. 2017;112:740-751.
    PubMed     Text format     Abstract available


  61. STINE JG, Rinella ME
    Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?
    Am J Gastroenterol. 2017;112:752-754.
    PubMed     Text format     Abstract available


    April 2017
  62. WONG F, O'Leary JG, Reddy KR, Garcia-Tsao G, et al
    Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  63. LEE MH, Hsiao TI, Subramaniam SR, Le AK, et al
    HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  64. CHEN SC, Chao Y, Yang MH
    Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report.
    Am J Gastroenterol. 2017;112:659-660.
    PubMed     Text format    


    March 2017
  65. JOHN BV, Khalili K
    Editorial: Not All Nodules Are Created Equal: A Personalized Approach to Indeterminate (<2 cm) Nodules Identified on HCC Surveillance.
    Am J Gastroenterol. 2017;112:471-472.
    PubMed     Text format     Abstract available


    January 2017
  66. FELDMAN A, Eder SK, Felder TK, Kedenko L, et al
    Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.
    Am J Gastroenterol. 2017;112:102-110.
    PubMed     Text format     Abstract available


  67. ARGO CK, Henry ZH
    Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI... Is It in the Genes?
    Am J Gastroenterol. 2017;112:111-113.
    PubMed     Text format     Abstract available


    October 2016
  68. FLOREANI A, Mangini C, Reig A, Franceschet I, et al
    Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers.
    Am J Gastroenterol. 2016 Oct 25. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    July 2016
  69. FLORES A, Asrani SK
    Editorial: Magnetic Resonance Elastography and Non-Alcoholic Fatty Liver Disease: Time for an Upgrade?
    Am J Gastroenterol. 2016;111:995-6.
    PubMed     Text format     Abstract available


    June 2016
  70. KISHORE R, Loomba R, Sterling RK
    Editorial: A New Spin on Magnetic Resonance Elastography.
    Am J Gastroenterol. 2016;111:834-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: